Clinical Trial: [68Ga]BED003 PET Imaging of Fibroblast Activation Protein in Selected Oncology Indications

U.S., July 15 -- ClinicalTrials.gov registry received information related to the study (NCT07702292) titled '[68Ga]BED003 PET Imaging of Fibroblast Activation Protein in Selected Oncology Indications' on June 30.

Brief Summary: This is a multi-centre, open-label, single-arm, Phase 2 study designed to evaluate the diagnostic performance of [68Ga]BED003 in detecting colorectal cancer (CRC), gastric cancer (GC), pancreatic ductal adenocarcinoma (PDAC), invasive lobular breast cancer (ILC), and epithelial ovarian cancer (EOC).

Study Start Date: June, 2026

Study Type: INTERVENTIONAL

Condition: Colorectal Cancer Epithelial Ovarian Cancer Gastric Cancer (GC) Pancreatic Ductal Adenocarcinoma (PDAC) Invasive Lobular Breast Carcinoma

Interventi...